ClinicalTrials.gg
CompletedNCT07924163MyoLingualUpdated Nov 9, 2026

Impact of Lingual Frenulum Variations on Orofacial Growth in Children

An observational study in Ankyloglossia, sponsored by Istanbul Health and Technology University. Completed at 2 sites in Turkey (Türkiye). Open to participants aged 7 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Istanbul Health and Technology University · Observational

Updated Nov 9, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
170
Ages
7 Years to 12 Years
Sex
All
01

Study summary

This study aimed to evaluate the impact of lingual frenulum morphology on orofacial myofunctional functions in children during the mixed dentition period.

Read the detailed description

Orofacial myofunctional disorders are known to affect essential functions such as swallowing, breathing, and resting tongue posture, especially in growing children. Variations in lingual frenulum anatomy may contribute to such dysfunctions and influence orofacial development.

02

Conditions studied

  • Ankyloglossia

Browse trials for

03

In context

Ankyloglossia

32 studies on the registry are indexed under Ankyloglossia; 8 are open to participants now.

Browse Ankyloglossia studies →

Lead sponsor

Istanbul Health and Technology University is the lead sponsor of 5 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Healthy children aged 7-12 years with fully erupted permanent maxillary central incisors and the ability to cooperate during clinical oral and speech evaluations. Children undergoing orthodontic treatment or presenting with cleft lip/palate, delayed incisor eruption, or speech impairments were excluded.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children whose parents or legal guardians provided written
  • Ability to cooperate with clinical evaluation protocols
  • Presence of fully erupted permanent maxillary central incisors

Exclusion criteria

Exclusion Criteria:

  • Currently undergoing orthodontic treatment
  • Presence of cleft lip and/or cleft palate
  • Inability to complete speech evaluation
  • Permanent maxillary incisors not yet erupted
  • Parental consent not obtained
  • Inability to cooperate with examination procedures
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
170 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Tongue Range of Motion Ratio (TRMR, %)

    TRMR (%) is calculated by dividing the interincisal distance with the tongue tip on the incisive papilla by the maximum mouth opening, multiplied by 100. Both distances are measured in millimeters using a digital caliper and averaged over three repetitions.

    Time frame: Baseline (single study visit)

  2. Diagnosis of Ankyloglossia Based on the Marchesan Protocol

    Ankyloglossia was assessed using the standardized lingual frenulum evaluation protocol developed by Irene Marchesan (Marchesan, 2012). The protocol includes anatomical and functional observations and yields a diagnostic score. Participants were classified as having ankyloglossia or not based on the cut-off values defined in the protocol.

    Time frame: Baseline (single study visit)

Secondary outcomes

  1. Mentalis Muscle Activity

    Mentalis muscle activity during swallowing was assessed through clinical observation and manual palpation, following the Orofacial Myofunctional Evaluation with Scores (OMES) protocol.

    Time frame: Baseline (single study visit)

  2. Swallowing Pattern

    Swallowing pattern was evaluated through observation of tongue posture following the Orofacial Myofunctional Evaluation with Scores (OMES) protocol

    Time frame: Baseline (single study visit)

  3. Breathing Pattern

    Breathing pattern was classified based on clinical observation of habitual respiratory behavior at rest. Participants were categorized as having nasal, oral, or mixed breathing following the Orofacial Myofunctional Evaluation with Scores (OMES) protocol

    Time frame: Baseline (single study visit)

07

Study locations

2 sites
  • Istanbul Health and Technology University
    Istanbul, Istanbul 34275, Turkey (Türkiye)
  • Istanbul Health and Technology University
    Istanbul, Turkey (Türkiye)
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2024 to primary completion in Oct 2024, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 6, 2025
First posted
Nov 9, 2026
StartActual
May 31, 2024
Primary completionActual
Oct 31, 2024
CompletionActual
Oct 31, 2024
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07924163
Lead sponsor
Istanbul Health and Technology University
Responsible party
Gulce Esenturk (Assistant Professor of Pediatric Dentistry, Istanbul Health and Technology University) — Principal investigator
First posted
Nov 9, 2026
Start date
May 31, 2024
Primary completion
Oct 31, 2024
Completion
Oct 31, 2024
Last update
Nov 9, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion